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Abstract
Background: Engagement in healthy lifestyle behaviors, such as healthy diet and regular physical activity, are
known to reduce the risk of developing coronary heart disease (CHD). Complementary and alternative medicine
(CAM) is known to be associated with having a healthy lifestyle. The primary aim of this study was to examine the
prevalence and predictors of CAM use in CHD patients, and in those without CHD but at risk for developing CHD,
using Protection Motivation Theory (PMT) as a guiding conceptual framework.
Method: Questionnaire data were collected from 12,981 adult participants in the cross-sectional sixth Tromsø Study
(2007–8). Eligible for analyses were 11,103 participants who reported whether they had used CAM or not. Of those,
830 participants reported to have or have had CHD (CHD group), 4830 reported to have parents, children or siblings
with CHD (no CHD but family risk), while 5443 reported no CHD nor family risk of CHD. We first compared the patterns
of CAM use in each group, and then examined the PMT predictors of CAM use. Health vulnerability from the threat
appraisal process of PMT was assessed by self-rated health and expectations for future health. Response efficacy from
the coping appraisal process of PMT was assessed as preventive health beliefs and health behavior frequency.
Results: Use of CAM was most commonly seen in people with no CHD themselves, but family risk of developing CHD
(35.8%), compared to people already diagnosed with CHD (30.2%) and people with no CHD nor family risk (32.1%). All
four of the PMT factors; self-rated health, expectations for future health, preventive health beliefs, and the health
behavior index – were predictors for CAM use in the no CHD but family risk group.
Conclusion: These findings suggest that people use CAM in response to a perceived risk of developing CHD, and
to prevent disease and to maintain health.
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Background
Cardiovascular disease is the most common cause of
death in Norway [1] and Europe [2]. However, mortality
rates have decreased significantly over the past years
both for coronary heart disease (CHD) and stroke [2],
partly because survival after acute myocardial infarction
has improved substantially [3]. Risk factors for the develop-
ment of CHD include non-modifiable factors such as family
history of CHD, and modifiable factors including health
behaviors and stress [4]. Engagement in healthy lifestyle
behaviors, such as healthy diet and regular physical activity,
are known to reduce the risk of developing CHD [5–7]. Pri-
mary prevention of CHD involves encouraging individuals
at risk to make healthy lifestyle changes to reduce the risk.
Increasingly, individuals interested in improving their
health and making healthy lifestyle changes are turning
to complementary and alternative medicine (CAM) as a
self-care and health-care option [8, 9]. CAM use is asso-
ciated with other healthy lifestyle behaviors such as diet
and physical activity in national surveys from the U.S.
[10, 11], Canada [12], Germany [13] and Australia [14].
Taken together with qualitative and quantitative research
indicating that CAM providers help promote healthy
lifestyles in their clients [15], this evidence indicates that
individuals may apply CAM modalities as a means to
achieve a healthy lifestyle, maintain health, and to reduce
the chances of developing disease. Indeed maintaining a
healthy lifestyle is generally accepted as important for
reducing risk of developing diseases such as CHD, espe-
cially among those with increased risk due to non-
modifiable factors [16]. Despite the known links between
CAM use and engaging in healthy behaviors and the role
of healthy behaviors in reducing modifiable CHD risk
[4], little is known about the patterns and reasons for
CAM use among those at risk for developing CHD.
Protection Motivation Theory (PMT) is a social cognitive
model for predicting health behavior that may be useful for
better understanding CAM use as a health protective
behavior among those at risk for CHD [17–19]. This theory
provides a framework for understanding motivations to en-
gage in protective behaviors in response to health threats.
Specifically, the PMT posits that a protection motivation
results from two appraisal processes, a threat appraisal,
followed by a coping appraisal. The threat appraisal in-
volves assessing the perceived severity of the threat, as well
as the probability of being vulnerable to the threat. This
appraisal is based on perceptions of vulnerability, which
may or may not rely on objective indicators of vulnerability
for a particular health threat. Perceiving that one is at risk,
for example by having non-modifiable risk factors, is
enough to activate perceptions of vulnerability and corre-
sponding health protective behaviors such as CAM use.
Once a threat is perceived as being severe and involving
personal vulnerability, a coping appraisal process is initiated
to deal with the threat. The coping appraisal includes
assessing the efficacy of the health behavior for dealing
with the threat (response efficacy), as well as the indi-
vidual’s self-efficacy or confidence for being able to en-
gage in the behavior.
PMT is most commonly used for assessing how people
respond to health risk messages, such as those in the
media or delivered by a health-care professional about
needed changes in health behavior to reduce risk of
disease [20, 21]. However, PMT is also used for understand-
ing a more general response to health threats including
knowledge about one’s own risk for developing disease,
based on risk factors such as family history of CHD,
and the health protective behaviors that my reduce this
risk [19].
Research describing prevalence and pattern of use of
CAM in patients with CHD is sparse [22]. The few exist-
ing studies is in highly selected population subgroups,
with substantial differences in proportion of CAM users
ranging from 4%–85% [23–27]. Similar to patients with
other chronic diseases, CHD patients are likely to use
CAM to manage their condition, increase quality of life
and prevent recurrence of their disease [28]. CAM use
for general health purposes has also been reported in
CHD patients [29]. The use of CAM in patients with
CHD has been mapped in Norway, finding that 6.4% of
patients with CHD had visited a CAM provider within
the last 12 months [30]. Examining CAM use and the
factors associated with CAM use among patients with
CHD, and with non-modifiable risk factors for CHD,
would contribute to the limited knowledge on CAM use
in these groups.
The primary aim of this study was to examine the
prevalence and predictors of CAM use in CHD patients,
and in those without CHD but with non-modifiable risk
for developing CHD, using PMT as a guiding conceptual
framework. Based on current theory and evidence, we
hypothesized that the set of PMT factors would be
significant predictors of CAM use in the CHD family risk
group and to a lesser extent in the CHD patient group.
Method
The sixth Tromsø study is part of a single-centered
population based health survey of adult inhabitants of
the municipality of Tromsø in the northern part of
Norway. It is a collaborative study in the interface between
epidemiology and clinical medicine, including a main study
that comprised two screening visits, two questionnaires and
several follow-up studies [31]. The design includes
repeated population health surveys to which total
birth cohorts and random samples are invited.
To the sixth study, conducted in 2007–2008 the following
subjects were invited: All participants who participated in
the 2.nd visit of the fourth Tromsø study (1994–1995), a
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random sample of 10% of all inhabitants in the municipality
of Tromsø aged 30–39 years, all inhabits in the municipality
of Tromsø aged 40–42 years and 60–87 years, in addition to
a random sample of 40% of all inhabitants in the municipal-
ity of Tromsø aged 43–59. A total of 12,982 people
participated, with a response rate of 65.7%.
Individuals who attended the study by undergoing a
health screening and answering the first questionnaire,
received a second, more detailed questionnaire to complete
and return at site of the health screening or later by mail.
The questionnaires included questions about self-reported
health, diseases suffered by the respondent or close family,
food-, alcohol- and smoking habits, physical activity,
education, general use of medication, and health services
including CAM, not related to any specific condition or
disease. The material used in this study is drawn from the
two questionnaires described above. The population of
Tromsø reflects the distribution of gender, and average
income in Norway, although somewhat younger [32] and
higher educated [33].
Measures
The three main groups describing the different CHD
profiles were defined as follows (Fig. 1): The CHD group:
People reporting to have or have had heart attack and/or
angina pectoris regardless of family risk, The no CHD
but family risk group: People not reporting to have or
have had CHD, but who have parents, children or sib-
lings with heart attack and/or angina pectoris and the
The no CHD nor family risk group: People not reporting
to have or have had CHD, nor parents, children or sib-
lings with heart attack and/or angina pectoris.
The definition of a CAM user was based on three
questions, one from the first questionnaire following the
invitation to participate in the study (question 1), and
two from the second questionnaire recieved on site of
the health screening (question 2 and 3). Over all users of
CAM consisted of informants who indicated YES for at
least one of the following questions:
1. Have you during the past year visited an alternative
medical practitioner (homeopath, acupuncturist, foot
zone therapist, herbal medicine practitioner, laying
on of hands practitioner, healer, clairvoyant etc.)?
2. Have you in the last 12 months used herbal or
natural medicine?
3. Have you in the last 12 months used meditation,
yoga, qi gong or thai-chi as self-treatment?
CAM was studied and described specifically for overall
CAM use, as well as specifically for
1. Use of a CAM provider, 2. Over the counter (OTC)
CAM products, and 3. CAM self-care approaches.
We first compared the patterns of CAM use between
participants with CHD, and participants at risk of devel-
oping CHD, with participants with no CHD nor risk.
Based on PMT, we hypothesized that those at risk for
CHD would use more CAM than the other two groups
as a means to reduce their risk for developing CHD. Risk
for CHD was in this study conceptualized by having a
family history of CHD (i.e., parents, children, or siblings
with CHD).
PMT variables
Health vulnerability was assessed from the following two
questions about self-rated health and future health beliefs:
How do you in general consider your own health to be?
(Very bad, Bad, Neither good nor bad, Good, Excellent)
and I have a positive view of my future health, (1. disagree
completely, 7. agree completely)
Response efficacy was assessed from two measures, the
first based on the questionnaire sentence I can prevent
serious diseases by living healthy, (1. disagree completely,
7. agree completely). The second measure was assessed
with a health behavior index. Although PMT is often used
to predict health behaviors [19], we considered that en-
gaging in health-promoting behaviors would be reflective
of efficacy for taking behavioral steps to reduce perceived
risk for developing CHD, and thus increase the chances
that CAM use would also be used to further reduce risk,
especially among those with non-modifiable risk factors
for CHD. The health behavior index was created from the
mean score of responses to questions about the frequency
of physical activity, eating fruit, vegetables and berries,
using omega 3 capsules and cod liver oil, and less use of
alcohol and beverages with sugar. Higher scores on the
health behavior index indicated a more frequent practice
of healthy behaviors.
We then examined the PMT predictors of CAM use.
The health vulnerability from the threat appraisal
process of PMT was assessed as current self-rated health
and expectations for future health. Current and expected
Fig. 1 The participants divided in the studied groups
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future health rated as poor were regarded as an indica-
tion of perceived vulnerability for CHD. Response effi-
cacy from the coping appraisal process of PMT was
assessed as endorsing preventive health beliefs (i.e., that
healthy living can reduce the risk of disease), and en-
gaging in more frequent healthy behaviours.
We defined three education response categories from
the original five: low (primary and part of secondary
school), middle (high school) and high (college or univer-
sity) education. The income variable referred to the house-
hold’s total gross income last year. Eight original response
categories were merged into low income (< NOK 301,000
(€ 34,000)), middle income (NOK 301,000–700,000
(€34,000–80,000)), and high income (> NOK 700,000
(€ 80,000)).
Statistical analysis
Between-group differences were analyzed using chi-
square tests for binary data analyzing one variable at the
time. Bivariate correlations among the PMT variables
were conducted with list wise deletion, stratified by each
of the three risk groups, to provide essential information
for understanding how each of these variables were inter-
related prior to assessing their roles in the multivariate
models. Three logistic regressions, one for each risk group,
were conducted to identify the variables associated with
CAM use from the set of PMT variables, while controlling
for age, sex, marital status, and income. All analyses were
conducted using SPSS for Windows (version 22.0, SPSS,
Inc., Chicago, IL). The significance level was set to p < 0.05.
Results
Basic characteristics of the participants
The studied population consisted of 5876 (52.9%) women
and 5227 (47.1%) men. Coronary heart disease was re-
ported in 7.47% (n = 830) of the participants, 43.5%
(n = 4830) had a family risk of CHD but no CHD them-
selves, while 49% (5443) were neither at risk nor diagnosed
with CHD (Fig. 2). The CHD group consisted of more
men than women. The family risk group consisted of more
women than men while the no CHD nor risk group were
gender balanced. Health was poorer and education lower
Did not accept invitation
6781
Accepted invitation
12981
No CHD nor family risk 
5443 
Missing information about CAM use
1878
CHD
830 
Included in the study
11103
Invited into the study
19762
The Tromsø population
64492
No CHD but family risk 
4830
Fig. 2 Flow chart of the included participants
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in the CHD group compared to the no CHD but family
risk and no risk nor CHD groups (Table 1).
Prevalence of CAM use
Over all CAM use was most commonly seen in the group
No CHD but family risk (35.8%, n = 1730) followed by the
No CHD nor risk group (32.1%, n = 1749) and CHD group
(30.2%, n = 251, p < 0.001). This was also the case for CAM
providers and OTC CAM products when the sub categories
were analyzed separately. CAM self-care approaches was,
however mostly used in the group with No CHD nor family
risk (Table 2).
Associations of PMT variables among CAM users
In all the three CHD groups self-rated health was
correlated with positive perceptions of future health, a be-
lief that serious illness can be prevented by living healthy,
but not with self-reported health behaviors (the health be-
havior index). Preventive health beliefs were significantly
correlated with beliefs about future health (Table 3).
CHD group
In those already diagnosed with CHD, current health
behaviors were not significantly associated with health
beliefs.
No CHD but family risk group
In this group, current practice of health behaviors were
significantly associated with preventive health beliefs,
but not with a positive belief about future health.
No CHD nor risk group
The health behavior index was significantly and mod-
estly associated with both health beliefs (preventive and
future health) in this group only.
Predictors of CAM use as a function of CHD Group
The results of the logistic regressions predicting
CAM use for each CHD group, revealed a pattern of
associations that was generally consistent with PMT
(Table 4). When adjusted for socio-demographic
Table 1 Basic characteristics of the participants
CHD (n = 830*) Family risk (n = 4830*) No CHD nor Risk (n = 5443*) p-value
% (n) % (n) % (n)
Mean age 68.46 57.07 54.67 < 0.001^
Gender < 0.001*
Men 65.5 (552) 41.9 (2022) 48.7 (2653)
Women 33.5 (278) 58.1 (2808) 51.3 (2790)
Marital status < 0.001*
Single 8.1 (67) 17.2 (829) 20.8 (1134)
Married 62.9 (522) 60.4 (2917) 58.4 (3179)
Separated/divorced 14.1 (117) 15.1 (728) 14.1 (766)
Widowed 14.9 (124) 7.4 (356) 6.7 (363)
Living with a spouse/partner 0.002*
Yes 72.0 (581) 75.1 (3541) 77.1 (4070)
No 28.0 (226) 24.9 (1172) 22.9 (1209)
Self-reported health 0.000a
Bad 12.2 (100) 4.8 (231) 4.4 (240)
Neither good nor bad 47.1 (385) 27.6 (1324) 25.0 (1352)
Good 40.7 (333) 67.6 (3246) 70.6 (3818)
Education < 0.001*
Low 44.5 (362) 26.5 (1267) 24.1 (1298)
Middle 32.5 (264) 35.2 (1686) 32.1 (1730)
High 23.0 (187) 38.3 (1831) 43.8 (2360)
Income < 0.001*
Low 45.3 (340) 22.7 (1034) 19.2 (980)
Middle 45.8 (344) 50.9 (2315) 50.7 (2586)
High 8.9 (67) 26.4 (1201) 30.1 (1533)
*Pearson’s Chi-Square test
^One-way ANOVA test
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variables, all four of the PMT factors - self-rated
health (OR 0.78, CI 0.69–0.88), expectations for future
health (OR 0.91, CI 0.85–0.98), preventive health be-
liefs (OR 1.09, CI 1.01–1.17), and the health behavior
index (OR 1.12, CI 1.09–1.14) were significant predic-
tors of CAM use for those with no CHD but family risk.
In the CHD group, only the health behavior index (OR
1.12, CI 1.05–1.20) and self-rated health (OR 0.72, CI
0.52–0.99) were significantly associated with CAM use.
In the no CHD nor family risk group, self-rated health
(OR 0.88, CI 0.72–0.90), the health behavior index (OR
1.10, CI 1.07–1.12), and future health beliefs (OR 0.90, CI
0.85–0.96) were the only PMT variables significantly as-
sociated with CAM use. Preventive health beliefs were
not a significant predictor.
The socio-demographic predictors of CAM use also
varied as a function of CHD risk groups. Being female
was associated with CAM use in both the No CHD nor
family risk (OR 1.92, CI 1.92–2.59) and the No CHD but
family risk groups (OR 2.30, CI 1.96–2.70), but not the
CHD group. Being younger was linked to CAM use
in the No CHD but family risk group only (OR 0.99,
CI 0.98–0.99).
Discussion
Use of CAM was most commonly seen in people with
no CHD themselves, but at risk of developing CHD. All
four of the PMT factors - self-rated health, expectations
for future health, preventive health beliefs, and the
health behavior index – were associated with CAM use
in the risk group. This provides suggestive evidences that
people use CAM in response to a health threat, to
prevent disease and to maintain health. The socio-
demographic factors associated with CAM use were
generally in line with those found for other chronic
health conditions [34], with being female and younger
linked to CAM use in some, but not all of the CHD risk
groups. Consistent with PMT [17, 18], use of CAM was
more common among people with no CHD but family
risk than in people with no CHD nor family risk or
already diagnosed with CHD. The full PMT set of
Table 3 Means, Standard Deviations (SD), and Bivariate Correlations Among the Health-Related Beliefs and Behavior Variables for
Each of the Coronary Heart Disease (CHD) Groups
Variable 1 2 3 4 Mean SD
A. CHD (N = 244)
1. Self-rated health — 69.45 16.72
2. Health behavior index .092 — 14.14 3.28
3. Preventive health beliefs .253** .047 — 5.89 1.34
4. Future health beliefs .595** .059 .339** — 4.56 1.43
B. No CHD but family risk (N = 1875)
1. Self-rated health — 77.94 15.76
2. Health behavior index .012 — 14.26 3.23
3. Preventive health beliefs .186** .093** — 6.02 1.14
4. Future health beliefs .606** .051 .420** — 5.07 1.37
C. No CHD nor family risk (N = 2267)
1. Self-rated health — 78.87 15.50
2. Health behavior index .016 — 13.83 3.32
3. Preventive health beliefs .210** .053* — 6.07 1.14
4. Future health beliefs .574** .054* .415** — 5.22 1.36
Note: *p < .01, **p < .001. N’s adjusted by list wise deletion
Table 2 CAM Use Within the Last 12 Months
CHD (N = 830) No CHD but family risk (N = 4830) No CHD nor family risk (N = 5443) P-value*
% (n) % (n) % (n)
CAM provider 9.4 (88) 12.8 (663) 11.6 (672) 0.007
OTC CAM products 20.8 (189) 25.4 (1273) 21.3 (1217) <0.001
CAM self-care approaches 1.6 (15) 5.2 (261) 5.5 (314) <0.001
Over all CAM use 30.2 (251) 35.8 (1730) 32.1 (1749) <0.001
*Pearson’s Chi-square test
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variables was also a significant predictor of CAM use in
the No CHD but family risk group.
Prevalence of CAM use in CHD
Our findings of 30.2% CAM use in patients already diag-
nosed with CHD is in accordance with a resent review
finding that 4–61% of the cardiac patients across 27 stud-
ies reported to use CAM [27]. The findings of 9.4% use of
a CAM provider is however somewhat higher than what
was found in the fifth Tromsø study conducted 6 years
earlier [30]. The main reason for this increase might be a
general increase in the use of CAM and a pre-prepared list
of CAM providers presented in the questionnaire that
might have improved the recall and clarified what to con-
sider as CAM [35]. The higher use of a CAM provider in
the No CHD nor family risk group is interesting and partly
in accodance with what was found in the fifth Tromsø
study where 6.5% in the CHD group and 9.5% in the No
cancer nor CHD group reported to have seen a CAM pro-
vider. The reason for higher use of CAM in the No CHD
nor family risk group than in the CHD group might there-
fore partly be due to the gender- and age differences found
in these groups, as older males are known to be less fre-
quent users of CAM [35]. The lower use of CAM in the
CHD group than in the No CHD but family risk group,
might in addition be due to the fact that patients already
diagnosed with CHD are taken care of within the conven-
tional health services to a greater extent than people with
a family risk only.
PMT correlates of CAM use across CHD risk groups
Framed from a PMT perspective, our findings indicate
that people with a family history that puts them at risk
for developing CHD, use CAM as a health-promoting
behavior to cope with, and minimize this perceived risk.
In this respect, our findings extend previous research in-
dicating that CAM users are proactive in their approach
to health [34, 36, 37], and that CAM is used alongside
other important health-promoting and preventive behav-
iors [8]. The high use of CAM in the group with no
CHD but family risk is also in accordance with findings
showing that one of the main reasons for CAM use is
disease prevention [38], and that CAM use is associated
with reducing risk factors such as being a former smoker
[8]. Our findings also highlight that CAM use may be
motivated by a protective response to perceptions of risk
for developing specific diseases, such as CHD, and not
just as a means of general disease prevention. Indeed,
the belief that by living healthy one can avoid disease,
was a significant predictor of CAM use only in those
with no CHD but family risk, and therefore perceived
risk of developing CHD, but not among those with no
CHD nor family risk.
Strengths and limitations
The main strength of this study is the large population-
based sample and the rather high response rate in addition
to the rich information about health-related issues. Despite
a high response rate, our sample may not be entirely
Table 4 Adjusted odds ratios (ORs) and 95% confidence intervals (95% CI) of factors independently associated with the use of CAM,
stratified by no coronary heart disease (CHD) but family risk group
CHD (n = 466)* No CHD but family risk (n = 3360)* No CHD nor family risk (n = 3838)*
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Age 0.98 0.96–1.01 0.235 0.99 0.98–0.99 0.013 1.00 0.99–1.00 0.430
Sexa)
2.23 1.18 0.72–1.92 0.517 2.30 1.96–2.70 2.23 2.23 1.92–2.59 < 0.001
Marital statusa)
1.00 1.00 — 0.319 1.00 — 1.00 1.00 — 0.488
0.99 0.76 0.28–2.07 0.594 1.07 0.72–1.61 0.99 0.99 0.66–1.48 0.941
1.03 0.66 0.32–1.36 0.261 1.14 0.80–1.64 1.03 1.03 0.71–1.50 0.861
1.0 1.13 0.50–2.57 0.766 1.12 0.76–1.66 1.0 1.0 0.79–1.77 0.408
Incomea)
1.0 1.0 — 0.597 1.0 — 1.0 1.0 — 0.313
1.17 1.56 0.62–3.51 0.325 1.07 0.85–1.66 1.17 1.17 0.91–1.52 0.220
1.13 1.46 0.67–3.21 0.344 1.27 0.39–0.92 1.13 1.13 0.95–1.34 0.156
Self-rated health 0.72 0.52–0.99 0.044 0.78 0.69–0.88 0.000 0.80 0.72–0.90 < 0.001
Health behavior index 1.12 1.05–1.20 0.001 1.12 1.09–1.14 0.000 1.10 1.07–1.12 0.001
Preventive health beliefs 1.00 0.85–1.17 0.971 1.09 1.01–1.17 0.019 1.07 1.00–1.14 0.056
Future health beliefs 0.99 0.84–1.18 0.944 0.91 0.85–0.98 0.008 0.90 0.85–0.96 0.002
*Note: N’s adjusted by list wise deletion. a)Reference categories were male, single and low income
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representative of the general population, as women, mar-
ried people, healthy people and higher socio-economic
groups are more likely to participate in population surveys.
In this particular study the participants were older and the
proportions of married people and women were higher
than for non-attendees [39].
Another limitation is that all information is self-
reported and may therefore be inaccurate due to recall
bias and individual definitions of CAM and heart attack/
angina pectoris. Further, the construction of the categor-
ies including only angina pectoris and heart attack in the
CHD group has some limitations when comparing CAM
use in this group with other studies. As well, the data
was collected at a single time point, making it difficult
to draw any causal conclusions about the relationships
between the PMT variables and CAM use. Nonetheless,
our suggestion that the variables predicted CAM use in
the regressions rather than vice versa, was informed by
established theory, PMT, which suggests that threat and
coping appraisals play a role in the behavioral responses
to perceived risk for illness [19]. Finally, the risk groups
were based on family history of CHD rather than on any
objectively measured physical risk factors, such as hyper-
tension, or high cholesterol, and therefore the groups
may not have been accurate with respect to actual risk
for CHD. However, we argue that it is the perceived risk
for CHD that is important in terms of people’s choice to
use CAM, and consistent with PMT [13, 14]. Feeling
vulnerable because of a family history of CHD may be
enough to motivate people to use CAM as a means to
help reduce this perceived threat.
Conclusions
This is one of few studies mapping CAM use in people
with coronary heart disease in Norway, and to our
knowledge, the first to apply PMT to understand the
health-related beliefs and behaviors associated with
CAM use in people at risk of developing CHD. The
study might therefore be a door opener to the field. Future
research should examine the extent to which CAM is used
to prevent specific diseases in response to perceived risks,
and as a primary prevention strategy among individuals
with known risk factors like a family history of disease,
diagnoses of specific disease precursors for CHD, for ex-
ample obesity, high cholesterol, and hypertension.
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